Bristol-Myers v. Teva Pharmaceuticals
1:01-cv-05572
Overview
Parties
Defendant
Teva Pharmaceuticals USA, Inc. Operating Company
Represented By
3 Attorneys ListedGoodwin Procter, LLP (Boston)
100 Northern Avenue, Boston, MA 02210
Goodwin, Procter, L.L.P.
Goodwin, Procter, L.L.P., 599 Lexington Avenue
Goodwin Procter, LLP (NYC)
The New York Times Building, 620 Eighth Avenue
Plaintiff
E.R. Squibb & Sons, LLC Operating Company
Represented By
2 Attorneys ListedFitzpatrick, Cella, Harper & Scinto
Fitzpatrick, Cella, Harper & Scinto, 30 Rockefeller Plaza
Fitzpatrick, Cella, Harper & Scinto
Fitzpatrick, Cella, Harper & Scinto, 30 Rockefeller Plaza
Bristol-Myers Squibb Company NPE (Individual / Inventor)
Represented By
2 Attorneys ListedFitzpatrick, Cella, Harper & Scinto
Fitzpatrick, Cella, Harper & Scinto, 30 Rockefeller Plaza
Fitzpatrick, Cella, Harper & Scinto
Fitzpatrick, Cella, Harper & Scinto, 30 Rockefeller Plaza
Court & Judges
Court
District Court, S.D. New York (nysd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 5,006,344 A Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 37,768,389 A | US Continuation / Sibling | View Official Patent → |
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5006344
Fosinopril tablet formulations
|
Filed: 1990-06-26
Issued: 1991-04-09
|
Expired (Term Ended)
Expires: 2010-06-26
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
1
Granted
1
Denied
1
Pending / Review
2
Motions by Category
Key Dispositive Motions & Rulings